Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

NASDAQ:ACLS - Nasdaq - US0545402085 - Common Stock - Currency: USD

78.01  +7.13 (+10.06%)

After market: 78.01 0 (0%)

Fundamental Rating

7

Overall ACLS gets a fundamental rating of 7 out of 10. We evaluated ACLS against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACLS has a decent growth rate and is not valued too expensively. This makes ACLS very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ACLS had positive earnings in the past year.
ACLS had a positive operating cash flow in the past year.
Each year in the past 5 years ACLS has been profitable.
ACLS had a positive operating cash flow in each of the past 5 years.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.35%, ACLS belongs to the top of the industry, outperforming 84.55% of the companies in the same industry.
ACLS's Return On Equity of 17.43% is amongst the best of the industry. ACLS outperforms 80.91% of its industry peers.
ACLS's Return On Invested Capital of 14.18% is amongst the best of the industry. ACLS outperforms 87.27% of its industry peers.
ACLS had an Average Return On Invested Capital over the past 3 years of 21.38%. This is significantly above the industry average of 10.72%.
The last Return On Invested Capital (14.18%) for ACLS is well below the 3 year average (21.38%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.35%
ROE 17.43%
ROIC 14.18%
ROA(3y)17.38%
ROA(5y)14.65%
ROE(3y)25.24%
ROE(5y)20.88%
ROIC(3y)21.38%
ROIC(5y)18.43%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS has a Profit Margin of 18.68%. This is amongst the best in the industry. ACLS outperforms 80.91% of its industry peers.
In the last couple of years the Profit Margin of ACLS has grown nicely.
Looking at the Operating Margin, with a value of 19.21%, ACLS is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
In the last couple of years the Operating Margin of ACLS has grown nicely.
With a Gross Margin value of 44.61%, ACLS perfoms like the industry average, outperforming 49.09% of the companies in the same industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.21%
PM (TTM) 18.68%
GM 44.61%
OM growth 3Y2.56%
OM growth 5Y24.06%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACLS is creating value.
Compared to 1 year ago, ACLS has less shares outstanding
ACLS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACLS has an improved debt to assets ratio.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 6.86 indicates that ACLS is not in any danger for bankruptcy at the moment.
The Altman-Z score of ACLS (6.86) is better than 69.09% of its industry peers.
The Debt to FCF ratio of ACLS is 0.35, which is an excellent value as it means it would take ACLS, only 0.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, ACLS belongs to the top of the industry, outperforming 80.91% of the companies in the same industry.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.04, ACLS is doing good in the industry, outperforming 60.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 6.86
ROIC/WACC1.3
WACC10.93%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.57 indicates that ACLS has no problem at all paying its short term obligations.
ACLS has a Current ratio of 5.57. This is amongst the best in the industry. ACLS outperforms 81.82% of its industry peers.
ACLS has a Quick Ratio of 4.09. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
ACLS has a better Quick ratio (4.09) than 74.55% of its industry peers.
Industry RankSector Rank
Current Ratio 5.57
Quick Ratio 4.09
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -25.76% in the last year.
ACLS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 64.54% yearly.
The Revenue for ACLS has decreased by -15.14% in the past year. This is quite bad
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 24.30% on average per year.
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%

3.2 Future

ACLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.02% yearly.
Based on estimates for the next years, ACLS will show a very negative growth in Revenue. The Revenue will decrease by -10.46% on average per year.
EPS Next Y-45.38%
EPS Next 2Y-22.39%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-25.36%
Revenue Next 2Y-10.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.88, ACLS is valued correctly.
ACLS's Price/Earnings ratio is rather cheap when compared to the industry. ACLS is cheaper than 92.73% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, ACLS is valued a bit cheaper.
A Price/Forward Earnings ratio of 21.06 indicates a rather expensive valuation of ACLS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACLS indicates a somewhat cheap valuation: ACLS is cheaper than 70.91% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.28. ACLS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.88
Fwd PE 21.06
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ACLS is valued cheaper than 85.45% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.27
EV/EBITDA 6.64
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The excellent profitability rating of ACLS may justify a higher PE ratio.
A more expensive valuation may be justified as ACLS's earnings are expected to grow with 24.02% in the coming years.
PEG (NY)N/A
PEG (5Y)0.22
EPS Next 2Y-22.39%
EPS Next 3Y24.02%

0

5. Dividend

5.1 Amount

No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (8/5/2025, 8:00:00 PM)

After market: 78.01 0 (0%)

78.01

+7.13 (+10.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners104.06%
Inst Owner Change-0.17%
Ins Owners0.95%
Ins Owner Change8.65%
Market Cap2.51B
Analysts72.86
Price Target88.86 (13.91%)
Short Float %16.95%
Short Ratio10.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)92.39%
Min EPS beat(2)20.83%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)49.55%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)32.98%
EPS beat(12)12
Avg EPS beat(12)27.59%
EPS beat(16)16
Avg EPS beat(16)26.09%
Revenue beat(2)2
Avg Revenue beat(2)1.57%
Min Revenue beat(2)1.02%
Max Revenue beat(2)2.12%
Revenue beat(4)3
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)2.12%
Revenue beat(8)7
Avg Revenue beat(8)1.66%
Revenue beat(12)11
Avg Revenue beat(12)1.99%
Revenue beat(16)15
Avg Revenue beat(16)2.52%
PT rev (1m)0%
PT rev (3m)4.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)47.47%
EPS NY rev (1m)0%
EPS NY rev (3m)41.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-2.76%
Valuation
Industry RankSector Rank
PE 13.88
Fwd PE 21.06
P/S 2.62
P/FCF 20.27
P/OCF 18.03
P/B 2.44
P/tB 2.44
EV/EBITDA 6.64
EPS(TTM)5.62
EY7.2%
EPS(NY)3.7
Fwd EY4.75%
FCF(TTM)3.85
FCFY4.93%
OCF(TTM)4.33
OCFY5.55%
SpS29.82
BVpS32
TBVpS32
PEG (NY)N/A
PEG (5Y)0.22
Profitability
Industry RankSector Rank
ROA 13.35%
ROE 17.43%
ROCE 16.13%
ROIC 14.18%
ROICexc 29.22%
ROICexgc 29.22%
OM 19.21%
PM (TTM) 18.68%
GM 44.61%
FCFM 12.91%
ROA(3y)17.38%
ROA(5y)14.65%
ROE(3y)25.24%
ROE(5y)20.88%
ROIC(3y)21.38%
ROIC(5y)18.43%
ROICexc(3y)45.43%
ROICexc(5y)37.56%
ROICexgc(3y)45.43%
ROICexgc(5y)37.56%
ROCE(3y)24.31%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.57%
ROICexcg growth 5Y39.04%
ROICexc growth 3Y-3.57%
ROICexc growth 5Y39.04%
OM growth 3Y2.56%
OM growth 5Y24.06%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.21
Cap/Depr 92.8%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 69.32%
Profit Quality 69.08%
Current Ratio 5.57
Quick Ratio 4.09
Altman-Z 6.86
F-Score6
WACC10.93%
ROIC/WACC1.3
Cap/Depr(3y)109.59%
Cap/Depr(5y)96.82%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.12%
Profit Quality(5y)99.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.76%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-33.76%
EPS Next Y-45.38%
EPS Next 2Y-22.39%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.14%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-23.7%
Revenue Next Year-25.36%
Revenue Next 2Y-10.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.22%
EBIT growth 3Y18.35%
EBIT growth 5Y54.2%
EBIT Next Year-45.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.94%
FCF growth 3Y-3.04%
FCF growth 5YN/A
OCF growth 1Y-38.06%
OCF growth 3Y-2.08%
OCF growth 5YN/A